Research
Hormonal
Tirzepatide demonstrates high clinical efficacy but has a higher Incremental Cost-Effectiveness Ratio (ICER), making its cost-effectiveness context-dependent.
Tirzepatide is a highly effective once-weekly peptide for weight loss, but its higher cost-effectiveness ratio means it may not be the most economical choice in all healthcare settings compared to Semaglutide.
GoodQualifiesHIGH confidence
Tirzepatide, despite its high efficacy, demonstrated a higher ICER, making its cost‑effectiveness context‑dependent.
Why this rating
Based on systematic review of economic evaluations.
Source
Economic Evaluation of Medications in Prevention and Treatment of Obesity: A Systematic Review
Somaye Afshari et al. · International Journal of Preventive Medicine · 2025
DOI 10.4103/ijpvm.ijpvm_368_24
systematic_review
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Semaglutide (2.4 mg) is the most cost-effective and clinically effective pharmacological intervention for obesity treatment compared to other FDA-approved medications and lifestyle interventions.Good
- Phentermine-topiramate (Qysmia) offers acceptable cost-effectiveness, particularly in low-resource settings, making it a practical alternative to more expensive drugs.Good
- Orlistat is an affordable option with lower effectiveness, making it a practical alternative in resource-limited settings.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →